1. Home
  2. AVDL vs TRS Comparison

AVDL vs TRS Comparison

Compare AVDL & TRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • TRS
  • Stock Information
  • Founded
  • AVDL 2015
  • TRS 1986
  • Country
  • AVDL Ireland
  • TRS United States
  • Employees
  • AVDL N/A
  • TRS N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • TRS Industrial Specialties
  • Sector
  • AVDL Health Care
  • TRS Industrials
  • Exchange
  • AVDL Nasdaq
  • TRS Nasdaq
  • Market Cap
  • AVDL 993.5M
  • TRS 1.1B
  • IPO Year
  • AVDL 1996
  • TRS 2007
  • Fundamental
  • Price
  • AVDL $10.48
  • TRS $24.37
  • Analyst Decision
  • AVDL Strong Buy
  • TRS Strong Buy
  • Analyst Count
  • AVDL 6
  • TRS 1
  • Target Price
  • AVDL $24.00
  • TRS $40.00
  • AVG Volume (30 Days)
  • AVDL 1.1M
  • TRS 211.7K
  • Earning Date
  • AVDL 11-12-2024
  • TRS 11-04-2024
  • Dividend Yield
  • AVDL N/A
  • TRS 0.64%
  • EPS Growth
  • AVDL N/A
  • TRS N/A
  • EPS
  • AVDL N/A
  • TRS 0.64
  • Revenue
  • AVDL $138,160,000.00
  • TRS $906,520,000.00
  • Revenue This Year
  • AVDL $523.86
  • TRS $4.36
  • Revenue Next Year
  • AVDL $70.46
  • TRS $4.92
  • P/E Ratio
  • AVDL N/A
  • TRS $38.83
  • Revenue Growth
  • AVDL 1523.50
  • TRS 2.17
  • 52 Week Low
  • AVDL $9.41
  • TRS $22.45
  • 52 Week High
  • AVDL $19.09
  • TRS $28.51
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 46.37
  • TRS 36.63
  • Support Level
  • AVDL $9.97
  • TRS $24.19
  • Resistance Level
  • AVDL $10.53
  • TRS $25.12
  • Average True Range (ATR)
  • AVDL 0.47
  • TRS 0.55
  • MACD
  • AVDL 0.12
  • TRS -0.09
  • Stochastic Oscillator
  • AVDL 61.43
  • TRS 26.89

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.

About TRS TriMas Corporation

TriMas Corp is a United States-based company that designs, manufactures, and distributes engineered and applied products. The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.

Share on Social Networks: